In a sweeping safety revision, the MHRA has updated the guidelines on domperidone usage, limiting its recommendation to treating nausea and vomiting. The update emphasizes minimal effective dosages and advisories for patients with heart or liver conditions, aiming to mitigate heart-related risks.